Subscribe to RSS
DOI: 10.1055/s-2004-827229
© Georg Thieme Verlag KG Stuttgart · New York
The Protective Effects of Ligustrazine on Ischemia-Reperfusion and DPPH Free Radical-Induced Myocardial Injury in Isolated Rat Hearts
Publication History
Received: February 6, 2004
Accepted: May 15, 2004
Publication Date:
23 September 2004 (online)

Abstract
Previous investigations have suggested that tumor necrosis factor-alpha (TNF-α) can contribute to myocardial damage during ischemia-reperfusion. In the present study, we examined whether the cardioprotective effects of ligustrazine are related to inhibition of TNF-α production in the rat models of ischemia-reperfusion and 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical-induced myocardial injury. Ischemia for 20 min and reperfusion for 40 min caused a decline in cardiac function (left ventricular pressure, ± dp/dt max, heart rate and coronary flow) and an increase in the release of creatine kinase in coronary effluent and the content of TNF-α in myocardial tissues. Similarly, perfusion with DPPH (100 nM) for 30 min significantly decreased cardiac function, and increased the release of creatine kinase and the content of TNF-α. Ligustrazine at the concentration of 40 or 80 mg/L markedly improved cardiac function and reduced the release of creatine kinase and the content of TNF-α in myocardial tissues in hearts subjected to ischemia-reperfusion or DPPH perfusion. These results suggest that the cardioprotection afforded by ligustrazine is related to a reduction of TNF-α content by inhibition of free radical production in isolated rat hearts.
Key words
Ligustrazine - tumor necrosis factor-alpha - myocardial ischemia-reperfusion injury - 1,1-diphenyl-2-picrylhydrazyl - rat isolated heart - Ligusticum wallichii - Apiaceae
References
- 1 Marban E, Koretsune Y, Corretti M, Chacko V P, Kusuoke H. Calcium and its role in myocardial cell injury during ischemia reperfusion. Circulation. 1989; 80 IV17-22
- 2 Goldhaber J I, Weiss J N. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension. 1992; 20 118-27
- 3 Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol Ther. 2002; 94 123-35
- 4 Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, Mohr R. et al . Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia reperfusion. J Am Coll Cardiol. 1996; 28 247-52
- 5 Li Y J, Peng J. The cardioprotection of calcitonin gene-related peptide-mediated preconditioning. Eur J Pharmacol. 2002; 442 173-7
- 6 Kwan C Y, Daniel E E, Chen M C. Inhibition of vasoconstriction by tetramethylpyrazine: does it act by blocking the voltage dependent Ca2+ channel?. J Cardiovasc Pharmacol. 1990; 15 157-62
- 7 Jiang D J, Hu G Y, Jiang J L, Xiang H L, Deng H W, Li Y J. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Bioorg Med Chem. 2003; 11 5171-7
- 8 Hu C P, Xiao L, Deng H W, Li Y J. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med. 2002; 68 705-9
- 9 Ferrari R, Visioli O. Protective effects of calcium antagonists against ischaemia and reperfusion damage. Drugs. 1991; 42 14-26
- 10 Chen J B, Huang C X, Tang Q J, Li J J, Xu J L, Li G S. Electrophysiological effect of tetramethylpyrazine on ventricular myocardium. Acta Acad Med Hubei. 1999; 20 111-3
- 11 Jin Z Q, Chen X. A simple reproducible model of free radical-injury isolated heart induced by 1,1-diphenyl-2-picryl-hydrazyl (DPPH). J Pharmacol Toxicol Method. 1998; 39 63-70
- 12 Frangogiannis N G, Lindsey M L, Michael L H, Youker K A, Bressler R B, Mendoza L H. et al . Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation. 1998; 98 699-710
- 13 Krown K A, Page M T, Nguyen C, Zechner D, Gutierrez V, Comstock K L. et al . Tumor necrosis factor-alpha induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac myocytes. J Clin Invest. 1996; 98 2854-65
Yuan-Jian Li, M.D.
Department of Pharmacology
School of Pharmaceutical Sciences
Central South University
No. 110 Xiang-Ya Road
Changsha
Hunan 410078
P. R. China
Phone: (+86)-731-235-5078
Fax: (+86)-731-235-5078
Email: yuan_jianli@yahoo.com